|
|
Impact of Comorbidities on Stroke Outcomes and Treatments |
| RX001141-05A1 |
TOMLINSON, STEPHEN |
VA |
2023 |
|
|
Muscle stem cell therapy for volumetric muscle loss |
| RX001222-05A2 |
HUANG, NGAN F |
VA |
2023 |
|
|
Bioactive injectable implants for functional intervertebral disc regeneration |
| RX001321-06A1 |
MAUCK, ROBERT L |
VA |
2023 |
|
|
Autonomic Regulation of the Immunological Response to Limb Injury |
| RX001475-06A1 |
CLARK, DAVID J |
VA |
2023 |
|
|
Neurophysiological Basis for Enhancing Motor Recovery After Stroke |
| RX001640-05A1 |
GANGULY, KARUNESH |
VA |
2023 |
|
|
RR&D Gordon Mansfield Spinal Cord Injury Consortium |
| RX001706-06 |
TUSZYNSKI, MARK H |
VA |
2023 |
|
|
Traumatic Brain Injury and Endogenous Pain Modulation |
| RX001776-05 |
CLARK, DAVID J |
VA |
2023 |
|
|
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma |
| RX001985-01A2 |
WILLETT, NICK J |
VA |
2023 |
|
|
Novel Pharmacological and Non-pharmacological Interventions for Bone Loss in SCI |
| RX002089-01A2 |
QIN, WEIPING |
VA |
2023 |
|
|
Modulating microglial phenotype to prevent SCI-induced central neuropathic pain |
| RX002099-01A1 |
GHOSH, MOUSUMI |
VA |
2023 |
